U.S. Stem Cell Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
Depreciation, Depletion & Amortization
2.20
4.50
5.30
5.80
178.70
207.10
Other Funds
215.50
33.80
13.60
15.00
-
1,918.30
Funds from Operations
2,609.10
2,168.00
1,712.50
242.30
320.60
35
Changes in Working Capital
695.80
1,059.30
867.80
354.50
910.80
637.40
Net Operating Cash Flow
1,913.30
1,108.60
844.70
112.20
1,231.40
602.50
Capital Expenditures
9.40
8.10
2.00
12.60
1.20
Sale of Fixed Assets & Businesses
-
-
-
0.50
400.00
Purchase/Sale of Investments
-
-
10.00
175.00
225.00
Net Investing Cash Flow
9.40
57.80
234.00
155.10
723.80
Issuance/Reduction of Debt, Net
326.60
507.50
504.00
130.00
1,514.20
Net Financing Cash Flow
1,969.00
1,156.90
1,100.40
55.00
1,239.20
Net Change in Cash
46.20
9.60
21.70
212.30
716.10
Free Cash Flow
1,922.80
1,116.80
846.70
99.70
1,230.20
Other Sources
-
-
-
-
100.00
Change in Capital Stock
1,426.90
615.60
582.80
60.00
275.00
Other Uses
-
49.70
222.00
7.80
-
About U.S. Stem Cell
View Profile
